TRIER PHARM ApS: Financial statements 2016
CVR: 31611083
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 494,000 and a net result of DKK -599,533 compared with DKK -232,221 the year before. That is a decrease of 16.8% compared with the year before. The profit margin was -121.4%. Equity in the 2016 report amounted to DKK -360,875.
- Revenue
- DKK 494,000
- Gross Profit
- DKK 178,541
- Profit/Loss
- DKK -599,533
- Equity
- DKK -360,875
- Total Assets
- DKK 456,471
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 494 t. | 179 t. | -600 t. | -361 t. | - |
| 2015 | 594 t. | -209 t. | -232 t. | 239 t. | - |
| 2014 | 387 t. | -272 t. | -285 t. | 471 t. | - |
| 2013 | 261 t. | -17 t. | -21 t. | 756 t. | - |
| 2012 | 177 t. | 53 t. | 43 t. | 778 t. | - |
Official annual report
Find more companies like TRIER PHARM ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
TRIER PHARM ApS has published its annual report for 2015. Revenue came to DKK 593,750, and the net result was DKK -232,221.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.